Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1990 Mar;43(3):213–219. doi: 10.1136/jcp.43.3.213

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

U Latza 1, G Niedobitek 1, R Schwarting 1, H Nekarda 1, H Stein 1
PMCID: PMC502333  PMID: 1692040

Abstract

A new monoclonal antibody, Ber-EP4, directed against a partially formol resistant epitope on the protein moiety of two 34 kilodalton and 39 kilodalton glycopolypeptides on human epithelial cells is described. Immunostaining of a wide range of normal and neoplastic human tissues and cell lines showed that all carcinomas and all non-neoplastic epithelial cells, except hepatocytes, parietal cells, and apical cell layers in squamous epithelia, homogeneously expressed Ber-EP4 antigen. As Ber-EP4 does not detect any normal or neoplastic non-epithelial cells, this antibody might prove valuable for the differentiation of the following (i) non-epithelial tumours from undifferentiated carcinomas; (ii) hepatocytes from bile duct cells in certain liver diseases; (iii) mesothelial cells from carcinoma cells in lung biopsy specimens; and (iv) reactive mesothelial cells from carcinoma cells in smears of serous effusions.

Full text

PDF
215

Images in this article

214Image
on p.214
214Image
on p.214
215Image
on p.215
216Image
on p.216
216Image
on p.216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper D., Schermer A., Sun T. T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest. 1985 Mar;52(3):243–256. [PubMed] [Google Scholar]
  2. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  3. Cordell J., Richardson T. C., Pulford K. A., Ghosh A. K., Gatter K. C., Heyderman E., Mason D. Y. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer. 1985 Sep;52(3):347–354. doi: 10.1038/bjc.1985.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cordon-Cardo C., Mattes M. J., Melamed M. R., Lewis J. L., Jr, Old L. J., Lloyd K. O. Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarian carcinomas and other human tumors. Int J Gynecol Pathol. 1985;4(2):121–130. doi: 10.1097/00004347-198506000-00004. [DOI] [PubMed] [Google Scholar]
  5. Daffos F., Forestier F., Grangeot-Keros L., Capella Pavlovsky M., Lebon P., Chartier M., Pillot J. Prenatal diagnosis of congenital rubella. Lancet. 1984 Jul 7;2(8393):1–3. doi: 10.1016/s0140-6736(84)91993-7. [DOI] [PubMed] [Google Scholar]
  6. Damjanov I., Knowles B. B. Biology of disease. Monoclonal antibodies and tumor-associated antigens. Lab Invest. 1983 May;48(5):510–525. [PubMed] [Google Scholar]
  7. Diehl V., Kirchner H. H., Schaadt M., Fonatsch C., Stein H., Gerdes J., Boie C. Hodgkin's disease: establishment and characterization of four in vitro cell lies. J Cancer Res Clin Oncol. 1981;101(1):111–124. doi: 10.1007/BF00405072. [DOI] [PubMed] [Google Scholar]
  8. Dippold W. G., Klingel R., Bernhard H., Dienes H. P., Knuth A., Meyer zum Büschenfelde K. H. Secretory epithelial cell marker on gastrointestinal tumors and in human secretions defined by a monoclonal antibody. Cancer Res. 1987 Apr 15;47(8):2092–2097. [PubMed] [Google Scholar]
  9. Domagala W., Weber K., Osborn M. Diagnostic significance of coexpression of intermediate filaments in fine needle aspirates of human tumors. Acta Cytol. 1988 Jan-Feb;32(1):49–59. [PubMed] [Google Scholar]
  10. Edwards P. A. Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. Br J Cancer. 1985 Feb;51(2):149–160. doi: 10.1038/bjc.1985.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gatter K. C., Abdulaziz Z., Beverley P., Corvalan J. R., Ford C., Lane E. B., Mota M., Nash J. R., Pulford K., Stein H. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol. 1982 Nov;35(11):1253–1267. doi: 10.1136/jcp.35.11.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gatter K. C., Alcock C., Heryet A., Mason D. Y. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet. 1985 Jun 8;1(8441):1302–1305. doi: 10.1016/s0140-6736(85)92794-1. [DOI] [PubMed] [Google Scholar]
  13. Ghosh A. K., Gatter K. C., Dunnill M. S., Mason D. Y. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol. 1987 Jan;40(1):19–25. doi: 10.1136/jcp.40.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gröne H. J., Weber K., Gröne E., Helmchen U., Osborn M. Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol. 1987 Oct;129(1):1–8. [PMC free article] [PubMed] [Google Scholar]
  15. Henzen-Logmans S. C., Mullink H., Ramaekers F. C., Tadema T., Meijer C. J. Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue. Virchows Arch A Pathol Anat Histopathol. 1987;410(4):347–354. doi: 10.1007/BF00711291. [DOI] [PubMed] [Google Scholar]
  16. Jones D. B., Scott C. S., Wright D. H., Stein H., Beverley P. C., Payne S. V., Crawford D. H. Phenotypic analysis of an established cell line derived from a patient with Hodgkin's disease (HD). Hematol Oncol. 1985 Apr-Jun;3(2):133–145. doi: 10.1002/hon.2900030205. [DOI] [PubMed] [Google Scholar]
  17. Kamesaki H., Fukuhara S., Tatsumi E., Uchino H., Yamabe H., Miwa H., Shirakawa S., Hatanaka M., Honjo T. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood. 1986 Jul;68(1):285–292. [PubMed] [Google Scholar]
  18. Kasper M., Karsten U. Coexpression of cytokeratin and vimentin in Rathke's cysts of the human pituitary gland. Cell Tissue Res. 1988 Aug;253(2):419–424. doi: 10.1007/BF00222299. [DOI] [PubMed] [Google Scholar]
  19. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Lauder I., Holland D., Mason D. Y., Gowland G., Cunliffe W. J. Identification of large cell undifferentiated tumours in lymph nodes using leucocyte common and keratin antibodies. Histopathology. 1984 Mar;8(2):259–272. doi: 10.1111/j.1365-2559.1984.tb02340.x. [DOI] [PubMed] [Google Scholar]
  22. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
  23. Milani S., Herbst H., Schuppan D., Niedobitek G., Kim K. Y., Stein H. Vimentin expression of newly formed rat bile duct epithelial cells in secondary biliary fibrosis. Virchows Arch A Pathol Anat Histopathol. 1989;415(3):237–242. doi: 10.1007/BF00724910. [DOI] [PubMed] [Google Scholar]
  24. Moldenhauer G., Momburg F., Möller P., Schwartz R., Hämmerling G. J. Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer. 1987 Dec;56(6):714–721. doi: 10.1038/bjc.1987.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Momburg F., Moldenhauer G., Hämmerling G. J., Möller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res. 1987 Jun 1;47(11):2883–2891. [PubMed] [Google Scholar]
  26. Osborn M., Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest. 1983 Apr;48(4):372–394. [PubMed] [Google Scholar]
  27. Schwarting R., Stein H., Wang C. Y. The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. Blood. 1985 Apr;65(4):974–983. [PubMed] [Google Scholar]
  28. Stefanini M., De Martino C., Zamboni L. Fixation of ejaculated spermatozoa for electron microscopy. Nature. 1967 Oct 14;216(5111):173–174. doi: 10.1038/216173a0. [DOI] [PubMed] [Google Scholar]
  29. Stein H., Gatter K., Asbahr H., Mason D. Y. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest. 1985 Jun;52(6):676–683. [PubMed] [Google Scholar]
  30. Stein H., Gerdes J., Schwab U., Lemke H., Mason D. Y., Ziegler A., Schienle W., Diehl V. Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer. 1982 Oct 15;30(4):445–459. doi: 10.1002/ijc.2910300411. [DOI] [PubMed] [Google Scholar]
  31. Thorell J. I., Johansson B. G. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta. 1971 Dec 28;251(3):363–369. doi: 10.1016/0005-2795(71)90123-1. [DOI] [PubMed] [Google Scholar]
  32. Thotakura N. R., Bahl O. P. Enzymatic deglycosylation of glycoproteins. Methods Enzymol. 1987;138:350–359. doi: 10.1016/0076-6879(87)38030-9. [DOI] [PubMed] [Google Scholar]
  33. Wagener C., Breuer H. Biochemical and immunochemical aspects of carcinoembryonic antigen (CEA) and CEA related antigens: current status and future perspectives. J Clin Chem Clin Biochem. 1982 Oct;20(10):705–712. doi: 10.1515/cclm.1982.20.10.705. [DOI] [PubMed] [Google Scholar]
  34. Wano Y., Uchiyama T., Fukui K., Maeda M., Uchino H., Yodoi J. Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells. J Immunol. 1984 Jun;132(6):3005–3010. [PubMed] [Google Scholar]
  35. Warnock M. L., Stoloff A., Thor A. Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1. Am J Pathol. 1988 Oct;133(1):30–38. [PMC free article] [PubMed] [Google Scholar]
  36. Woodward M. P., Young W. W., Jr, Bloodgood R. A. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods. 1985 Apr 8;78(1):143–153. doi: 10.1016/0022-1759(85)90337-0. [DOI] [PubMed] [Google Scholar]
  37. Zauli D., Gobbi M., Crespi C., Tazzari P. L., Miserocchi F., Magnani M., Testoni N. Vimentin and keratin intermediate filaments expression by K562 leukemic cell line. Leuk Res. 1986;10(1):29–33. doi: 10.1016/0145-2126(86)90102-5. [DOI] [PubMed] [Google Scholar]
  38. van Eyken P., Sciot R., van Damme B., de Wolf-Peeters C., Desmet V. J. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol. 1987;412(1):63–72. doi: 10.1007/BF00750732. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES